AI companies could soon access the brain: Researcher warns of a new era
Neuroscientist Andrew Huberman predicts that AI and technology companies may evolve into biotech firms capable of reading and influencing brain activity without implants. Potential applications include personalized support for sleep, learning, concentration, motivation, and stress regulation. Consumer neurotechnology already includes focus-monitoring headphones, brain-stimulation headsets, and vagus-nerve-stimulation wearables, but current devices cannot precisely and reliably control motivation as Huberman envisions. He expects early advances to focus on sleep technology and stresses that future devices would need safety mechanisms. Huberman is optimistic that AI could eventually tailor stimulation to individuals, while the prospect of direct mental-state influence raises concerns about control and safety.
BerichtsstilAusgewogen
Mostly reported claims and product descriptions, with an optimistic outlook attributed to Huberman and limited critical analysis.